TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04785365

Long-Term Follow-Up Study of Patients Receiving ATL001

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“The long-term follow-up of patients is being migrated to the original (parent) study protocols (Trial ID: ATX-NS-001 / NCT: NCT04032847;Trial ID: ATX-ME-001 / NCT: NCT03997474). Consequently, the ATX-LTFU-001 study is being terminated by the Sponsor.”

The sponsor’s own words in the registry.

Life of this trial

2021202220232024Registered2021-03-01Started2022-06-01Stopped2023-10-18

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Achilles Therapeutics UK Limited
Sponsor type
Industry
Conditions
Melanoma; Advanced Non Small Cell Lung Cancer
Interventions
Biological: ATL001
Participants
1
Sites
1
Countries
United Kingdom

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.